Resources | NITAG RESOURCE CENTER

2024 ∙ Leon-Figueroa, D. A. Barboza, J. J. Valladares-Garrido, M. J. Sah, R. Rodriguez-Morales, A. J.

Prevalence of intentions to receive monkeypox vaccine. A systematic review and meta-analysis

2024 ∙ Pang, Y. Cao, D. Zhu, X. Long, Q. Tian, F. Long, X. Li, Y.

Safety and Efficacy of the Modified Vaccinia Ankara-Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis

2024 ∙ Han, Y. Wang, X. Li, X. Zhong, Z.

The willingness of healthcare workers to be vaccinated against monkeypox and their knowledge about monkeypox: A systematic review and meta-analysis

2024 ∙ Pischel, L. Martini, B. A. Yu, N. Cacesse, D. Tracy, M. Kharbanda, K. Ahmed, N. Patel, K. M. Grimshaw, A. A. Malik, A. A. Goshua, G. Omer, S. B.

Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis

2024 ∙ Liu, J. Liu, S. Yu, S. Du, X. Hao, J. Hui, R. Buh, A. Chen, W. Chen, J.

Willingness to receive mpox vaccine among men who have sex with men: a systematic review and meta-analysis

2024

MVA-BN (‎Modified Vaccinia Ankara – Bavarian Nordic)‎ smallpox and mpox vaccine: interim guidance

2024 ∙ SAGE

Smallpox and mpox (orthopoxviruses): WHO position paper, August 2024

2024 ∙ SAGE

Meeting of the Strategic Advisory Group of Experts on Immunization, March 2024: conclusions and recommendations

2024 ∙ SAGE

Meeting of the Strategic Advisory Group of Experts on Immunization, September 2024: conclusions and recommendations

2024

Updated recommendations for mpox vaccination in Spain